JPMorgan Chase & Co (JPM)
334.49
-2.85 (-0.84%)
NYSE · Last Trade: Nov 7th, 7:00 AM EST
Detailed Quote
| Previous Close | 337.34 |
|---|---|
| Open | 333.15 |
| Bid | 335.20 |
| Ask | 335.52 |
| Day's Range | 333.00 - 341.79 |
| 52 Week Range | 279.10 - 366.50 |
| Volume | 7,822,801 |
| Market Cap | 1.03T |
| PE Ratio (TTM) | - |
| EPS (TTM) | - |
| Dividend & Yield | 6.600 (1.97%) |
| 1 Month Average Volume | 7,419,219 |
Chart
About JPMorgan Chase & Co (JPM)
JPMorgan Chase & Co. is a leading global financial services firm that provides a wide range of financial solutions to consumers, businesses, and governments. The company offers investment banking, asset management, private banking, and wealth management services while also delivering a full suite of commercial banking products. With a strong emphasis on innovation and technology, JPMorgan Chase plays a pivotal role in the financial market, helping clients navigate complex financial landscapes through expert advice and tailored services. The firm is committed to maintaining its reputation for integrity and professionalism while actively contributing to economic development and community investment. Read More
News & Press Releases
JPMorgan Chase analyst Brian Essex believes Palantir is deeply undervalued.
Via The Motley Fool · November 7, 2026
DTE Energy (NYSE:DTE) plans to sell most of its DTE Vantage business in an approximately $3 billion transaction and redirect capital toward a larger utility investment program, as demand from data centers reshapes its growth outlook.
On its third-quarter earnings call, the company reported operatin
Via MarketBeat · November 7, 2026
Genius Sports (NYSE:GENI) reported third-quarter revenue and adjusted earnings above its guidance, raised its full-year outlook and said its acquisition of Legend was contributing to growth as competition for prediction market customers intensifies.
Revenue was $270 million, exceeding the company’s
Via MarketBeat · November 7, 2026
Eikon Therapeutics (NASDAQ:EIKN) expects an interim analysis of its lead melanoma study in the first half of 2027 and estimates that definitive data from that trial and a lung cancer study could be available around the middle of 2029, CEO Roger Perlmutter said during a JPMorgan biotech call.
Both s
Via MarketBeat · November 6, 2026
NuScale Power's market cap is now well under $3 billion.
Via The Motley Fool · November 6, 2026
What happened? Shares of healthcare staffing company AMN Healthcare Services (NYSE:AMN) fell 22.6% in the afternoon session after the company forecasted a 10...
Via StockStory · November 6, 2026
Thursday was the Nasdaq's worst day since April 2025. Here's what history says often comes next and how to make a rough market work for you.
Via The Motley Fool · November 6, 2026
Lee thinks the Ether cryptocurrency is entering a new era, and it could create significant value for investors.
Via The Motley Fool · November 6, 2026
Anthropic’s S-1 details a Nasdaq listing under the ticker ANT, first-half revenue of $16.3 billion and a net loss of $80.7 billion for the period, mostly from a financing adjustment, with external valuations of up to $2 trillion ahead of pricing
Via GlobePRwire · November 6, 2026
CION cuts debt to $897 million and sets up a new joint venture for loan sales.
Via The Motley Fool · November 5, 2026
Strategic review and rising reserves define a quarter of major balance sheet moves.
Via The Motley Fool · November 5, 2026
What happened? A number of stocks fell in the afternoon session after easing fears of a wider war with Iran continued to push oil prices lower. The pullback ...
Via StockStory · November 5, 2026
What happened? Shares of crude oil tanker operator DHT Holdings (NYSE:DHT) fell 5.6% in the afternoon session after easing fears of a wider war with Iran con...
Via StockStory · November 5, 2026
Bad results, stock up. Good results, stock down? This most recent round of big bank earnings has investors scratching their heads.
Via The Motley Fool · November 5, 2026
Dow Jones Top Decliners: NVIDIA and Cisco Post Steepest Losses in Today's Sessionchartmill.com
Via Chartmill · November 5, 2026
JPMorgan Chase & Co. (NYSE:JPM) is preparing for interest rates to move in either direction, but a rapid rise poses a broader risk to the financial system, according to Charles Bristow, the bank’s head of treasury and chief investment officer.
Bristow said the bank has stress-tested its balance
Via MarketBeat · November 5, 2026
Dow Biggest Decliners in the November 5, 2026 US Sessionchartmill.com
Via Chartmill · November 5, 2026
Chase Travel today released its annual 27 Trips to Take in 2027, a curated collection of destinations set to define travel in the year ahead. Selected by Chase Travel’s editors using firsthand reporting and proprietary booking data, the list spotlights the places to watch in 2027. Also to come in 2027, Chase Travel is offering an early look at its expansion of The Edit, a handpicked collection of hotels, resorts, and now, homes.
By Chase · Via Business Wire · November 5, 2026
The banking industry is doing just fine.
Via The Motley Fool · November 5, 2026
Bitcoin may have a difficult time delivering an encore performance over the next decade.
Via The Motley Fool · November 4, 2026
Falling oil prices and resilient travel demand could create an opportunity for airline stocks, but key differences give one carrier an advantage heading into 2027.
Via The Motley Fool · November 4, 2026
Some individual stocks keep falling. The broader U.S. stock market has always bounced back.
Via The Motley Fool · November 4, 2026
Crypto has only been around since 2009, but the sector's movement following midterms shows a clear trend.
Via The Motley Fool · November 4, 2026
JPMorgan Chase & Co. (NYSE: JPM) (“JPMorganChase” or the “Firm”) has filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2026 with the SEC. The report is available on the SEC's website at https://www.sec.gov and will be available on the Firm's Investor Relations website at https://www.jpmorganchase.com/ir under SEC Filings & Other Disclosures.
By JPMorgan Chase & Co. · Via Business Wire · November 3, 2026
NEW YORK, NY - November 2, 2026 - Michael Benabib, the corporate headshot photographer in New York City behind Executive Photos NYC, is expanding studio and on-location executive portrait sessions that apply the editorial approach he developed photographing for Forbes, The New York Times, Vanity Fair and The Wall Street Journal. As a corporate headshot photographer in New York City for more than 30 years, Benabib now photographs Fortune 500 executives, attorneys, physicians and full leadership teams on location and at his studio at 275 Fifth Avenue in Midtown Manhattan.
Via AB Newswire · November 2, 2026